Survival Benefits of Neoadjuvant Systemic Chemotherapy in Muscle Invasive Bladder Cancer

NCT06727214 · clinicaltrials.gov ↗

NOT_YET_RECRUITING

Status

87

Enrollment

OTHER

Sponsor class

Conditions

Bladder Urothelial Carcinoma

Interventions

DRUG: Chemotherapy with platine

Sponsor

Sara Mahmoud Ahmed Mahmoud